<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="in silico and in vitro approaches suggested the potential of" exact="sofosbuvir" post="(SFB), an antiviral prodrug clinically used against hepatitis C"/>
 <result pre="used a drug repurposing strategy to identify the macrolide antibiotic" exact="azithromycin" post="(AZT) as a potential anti-ZIKV drug. AZT was found"/>
 <result pre="(NMDA) glutamate receptor blockers, including MK-801, agmatine sulfate, ifenprodil, and" exact="memantine" post="(ME), in models of ZIKV-induced neuronal damage both in"/>
 <result pre="Our group has recently evaluated whether the TNF-α neutralizing antibody" exact="infliximab" post="(IFX) (20 μg/day) is able to prevent long-term consequences"/>
 <result pre="performed by Xu and colleagues also identified the anti-helmintic drug" exact="niclosamide" post="as a powerful antiviral drug against ZIKV, being able"/>
 <result pre="(Xu et al., 2016). In another study, two doses of" exact="niclosamide" post="(on embryonic days 3 and 5; 50 mg/kg) were"/>
 <result pre="viral entry in cells [122]. However, time-of-addition experiments indicate that" exact="niclosamide" post="is still effective even after viral cell invasion is"/>
 <result pre="which must be closely evaluated before clinical studies [127]. Therefore," exact="niclosamide" post="seems like a good candidate for management of infection"/>
 <result pre="6.7. Amodiaquine Another interesting antimalarial quinine with anti-ZIKV activity is" exact="amodiaquine" post="(AQ). A high-content screening study identified its ability to"/>
 <result pre="several viruses such as measles and rabies [131]. One specific" exact="adenosine" post="analog, NITD008, has been proven effective against a number"/>
 <result pre="An example in translational research suggesting the possible use of" exact="bumetanide" post="in newbornFront. Neurol.201343610.3389/fneur.2013.0003623596438 15.StagniF.GiacominiA.GuidiS.CianiE.BartesaghiR.Timing of therapies for Down syndrome:"/>
 <result pre="Fetal-like Organoids and Adult BrainCell Stem Cell201721274283.e510.1016/j.stem.2017.06.01728736217 81.HanY.MesplèdeT.XuH.QuanY.WainbergM.A.The antimalarial drug" exact="amodiaquine" post="possesses anti-ZIKA virus activitiesJ. Med. Virol.20189079680210.1002/jmv.2503129315671 82.RetallackH.DiE.AriasC.KnoppK.A.LaurieM.T.Zika virus cell"/>
 <result pre="in Different Cell ModelsViruses2016832210.3390/v8120322 85.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug" exact="chloroquine" post="for Zika Virus treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 86.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine,"/>
 <result pre="and implications to assess efficacy of antiviralsAntiviral Res.2017145828610.1016/j.antiviral.2017.07.01028736077 91.KimJ.A.SeongR.K.KumarM.ShinO.S.Favipiravir and" exact="ribavirin" post="inhibit replication of Asian and African strains of zika"/>
 <result pre="compounds using a cell-based, high-throughput screen assayAntivir. Res.2017138475610.1016/j.antiviral.2016.11.01827919709 98.YinZ.ChenY.-L.SchulW.WangQ.-Y.GuF.DuraiswamyJ.KondreddiR.R.NiyomrattanakitP.LakshminarayanaS.B.GohA.et al.An" exact="adenosine" post="nucleoside inhibitor of dengue virusProc. Natl. Acad. Sci. USA2009106204352043910.1073/pnas.090701010619918064"/>
 <result pre="Neuroepithelial Stem Cells and Radial GliaCell Rep.2016162576259210.1016/j.celrep.2016.08.03827568284 102.Bullard-FeibelmanK.M.GoveroJ.ZhuZ.SalazarV.VeselinovicM.DiamondM.S.GeissB.J.The FDA-approved drug" exact="sofosbuvir" post="inhibits Zika virus infectionAntiviral Res.201713713414010.1016/j.antiviral.2016.11.02327902933 103.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The"/>
 <result pre="infectionAntiviral Res.201713713414010.1016/j.antiviral.2016.11.02327902933 103.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved antiviral drug" exact="sofosbuvir" post="inhibits Zika virus replicationSci. Rep.201774092010.1038/srep4092028098253 104.YuY.DengY.Q.ZouP.WangQ.DaiY.YuF.DuL.ZhangN.N.TianM.HaoJ.N.et al.A peptide-based viral"/>
 <result pre="PregnancyAvailable online: https://clinicaltrials.gov/ct2/show/NCT02683005(accessed on 19 March 2019) 107.WiwanitkitS.WiwanitkitV.Doubled dosage of" exact="sofosbuvir" post="is expected for inhibiting Zika virus infectionAsian Pac. J."/>
 <result pre="and transplacental pharmacokinetics of azithromycinAm. J. Obstet. Gynecol.200318871471810.1067/mob.2003.14112634646 115.JaruratanasirikulS.HortiwakulR.TantisarasartT.PhuenpathomN.TussanasunthornwongS.Distribution of" exact="azithromycin" post="into brain tissue, cerebrospinal fluid, and aqueous humor of"/>
 <result pre="triclabendazole and oxamniquineInt. J. Risk Saf. Med.200820113122 122.KaoJ.C.HuangFuW.C.TsaiT.T.HoM.R.JhanM.K.ShenT.J.TsengP.C.WangY.T.LinC.F.The antiparasitic drug" exact="niclosamide" post="inhibits dengue virus infection by interfering with endosomal acidification"/>
 <result pre="nanoformulated antihelminthic, niclosamide, in ovarian cancerOncotarget201678993900610.18632/oncotarget.711326848771 124.ZhangX.ZhangY.ZhangT.ZhangJ.WuB.Significantly enhanced bioavailability of" exact="niclosamide" post="through submicron lipid emulsions with or without PEG-lipid: A"/>
 <result pre="FonsecaB.A.L.Chloroquine use improves dengue-related symptomsMem. Inst. Oswaldo Cruz201310859659910.1590/S0074-0276201300050001023903975 129.SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of" exact="chloroquine" post="on viral infections: An old drug against today’s diseasesLancet"/>
 <result pre="Dis.2003372272710.1016/S1473-3099(03)00806-514592603 130.TaylorW.R.J.WhiteN.J.Antimalarial Drug ToxicityDrug Saf.200427256110.2165/00002018-200427010-0000314720085 131.De ClercqE.BergstromD.E.JohnA.H.Broad-spectrum antiviral activity of" exact="adenosine" post="analoguesAntivir. Res.1984411913310.1016/0166-3542(84)90012-36476818 132.LoM.K.ShiP.-Y.ChenY.-L.FlintM.SpiropoulouC.F.In vitro antiviral activity of adenosine analog"/>
 <result pre="activity of adenosine analoguesAntivir. Res.1984411913310.1016/0166-3542(84)90012-36476818 132.LoM.K.ShiP.-Y.ChenY.-L.FlintM.SpiropoulouC.F.In vitro antiviral activity of" exact="adenosine" post="analog NITD008 against tick-borne flavivirusesAntivir. Res.2016130464910.1016/j.antiviral.2016.03.01327016316 133.EyerL.ZouharováD.ŠirmarováJ.FojtíkováM.ŠtefánikM.HaviernikJ.NenckaR.de ClercqE.RůžekD.Antiviral activity"/>
 <result pre="NITD008 against tick-borne flavivirusesAntivir. Res.2016130464910.1016/j.antiviral.2016.03.01327016316 133.EyerL.ZouharováD.ŠirmarováJ.FojtíkováM.ŠtefánikM.HaviernikJ.NenckaR.de ClercqE.RůžekD.Antiviral activity of the" exact="adenosine" post="analogue BCX4430 against West Nile virus and tick-borne flavivirusesAntivir."/>
</results>
